Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS
A Hybrid Score to Predict the Origin of Outflow Tract Ventricular Arrhythmias in Patients with Intraventricular Conduction Disorders or Paced Rhythm
1 other identifier
observational
100
3 countries
6
Brief Summary
Outflow tract ventricular arrhythmia (OTVA) is the most common type of ventricular arrhythmia, and catheter ablation (CA) is the primary treatment option for patients experiencing symptoms. Accurately identifying the origin site of OTVA is essential for effective catheter ablation, minimizing procedural risks, and enhancing treatment success. However, most studies that developed algorithms or scoring systems for distinguishing OTVA origins excluded participants with structural heart disease and those with paced rhythms from their study groups. A recent prospective evaluation of a hybrid score (HS) that integrates both clinical and ECG data to predict OTVA-SOO, including patients with cardiac implantable electronic devices and those with structural heart disease in our study. The presented study aimed to assess the effectiveness of the previously described hybrid algorithm in predicting OTVA-SOO in a patient population characterized by a wide basal QRS due to intraventricular conduction defects or paced rhythms. The Hybrid Score The Hybrid Score (HS), involves a sum of points based on clinical and ECG characteristics. Points are assigned as follows: one point each for being over 50 years old, male, and having arterial hypertension. ECG-based points are allocated according to QRS transition: 3 points for a transition in V1, 2 points for V2, 1 point for V3 if the R-wave in V3 is greater than 1 mV; 1 point is subtracted if V3 has an R-wave less than 1 mV, and further deductions or additions apply for transitions up to V6. A score ≤ 1 suggests an RVOT origin, whereas ≥ 2 suggests an LVOT origin. ECGs were recorded with a standard configuration at a 25 mm/s sweep speed. Premature Ventricular Contraction (PVC) Ablation Activation mapping of spontaneous OTVAs was conducted. The procedure aimed to abolish spontaneous OTVAs, with the site of ablation marking the site of origin (SOO). Collected data
- Patient Information and Consent (procedure must be done within 60 days of consent)
- Demographics (age, gender, etc.)
- Vital signs (length, weight, etc.)
- Medical history, including cardiovascular risk factors, cardiomyopathy and drugs
- ECG data
- Echocardiographic data (left ventricular ejection fraction and left ventricular end-diastolic diameter)
- Procedure data (number of radiofrequency applications, site of effective ablation, total radiofrequency time, total fluoro time, points mapping, procedure time)
- Adverse Events
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Typical duration for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2022
CompletedFirst Submitted
Initial submission to the registry
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2024
CompletedSeptember 24, 2024
September 1, 2024
2.7 years
September 9, 2024
September 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hybrid score performance
The primary endpoint of the study is to establish the sensibility and specificity of an already validated clinical and electrocardiographic score for the prediction of left or right outflow tract ventricular arrhythmias in a selected population with large QRS because of intraventricular conduction disorders or paced rhythm who underwent catheter ablation of the arrhythmia.
At the moment of interventional procedure
Secondary Outcomes (1)
Safety
1 month after the procedure date
Study Arms (2)
RVOT origin
Patients with right ventricular outflow tract (RVOT) arrhythmias origin
LVOT origin
Patients with left ventricular outflow tract (LVOT) arrhythmias origin
Interventions
The Hybrid Score (HS), detailed in previous literature involves a sum of points based on clinical and ECG characteristics. Points are assigned as follows: one point each for being over 50 years old, male, and having arterial hypertension. ECG-based points are allocated according to QRS transition: 3 points for a transition in V1, 2 points for V2, 1 point for V3 if the R-wave in V3 is greater than 1 mV; 1 point is subtracted if V3 has an R-wave less than 1 mV, and further deductions or additions apply for transitions up to V6. A score ≤ 1 suggests an RVOT origin, whereas ≥ 2 suggests an LVOT origin.
Eligibility Criteria
General population undergoing catheter ablation for outflow tract ventricular arrhythmias
You may qualify if:
- ventricular arrhythmia with a morphology indicating an outflow tract origin and a wide basal QRS complex
- a QRS width greater than 110 ms was considered wide
- willing and capable of providing written informed consent to the study
You may not qualify if:
- catether ablation procedure was unsuccessful
- infrequent arrhythmia requiring ablation guided by pacemapping.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centro Medico Teknonlead
- Hospital Universitario Puerta del Marcollaborator
- Vrije Universiteit Brusselcollaborator
- Cisanello University Hospital (Pisa, Italy)collaborator
- Maria Cecilia Hospitalcollaborator
Study Sites (6)
Vrije Universiteit Brussel
Brussels, Belgium, 1090, Belgium
Maria Cecilia Hospital
Cotignola, Italy, 48033, Italy
Niguarda Ca Granda Hospital
Milan, Italy, 20132, Italy
Cisanello University Hospital (Pisa, Italy)
Pisa, Italy, 56124, Italy
Teknon Medical Center
Barcelona, Spain, 08022, Spain
Hospital Universitario Puerta del Mar
Cadiz, Spain, 11009, Spain
Related Publications (2)
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262. No abstract available.
PMID: 36017572BACKGROUNDAnderson RD, Kumar S, Parameswaran R, Wong G, Voskoboinik A, Sugumar H, Watts T, Sparks PB, Morton JB, McLellan A, Kistler PM, Kalman J, Lee G. Differentiating Right- and Left-Sided Outflow Tract Ventricular Arrhythmias: Classical ECG Signatures and Prediction Algorithms. Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e007392. doi: 10.1161/CIRCEP.119.007392. Epub 2019 Jun 4.
PMID: 31159581BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
September 9, 2024
First Posted
September 19, 2024
Study Start
January 4, 2022
Primary Completion
September 30, 2024
Study Completion
October 23, 2024
Last Updated
September 24, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share